Page last updated: 2024-09-05

allantoxanamide and 3,4-dihydroxyphenylacetic acid

allantoxanamide has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

Compound Research Comparison

Studies
(allantoxanamide)
Trials
(allantoxanamide)
Recent Studies (post-2010)
(allantoxanamide)
Studies
(3,4-dihydroxyphenylacetic acid)
Trials
(3,4-dihydroxyphenylacetic acid)
Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid)
8005,41038591

Protein Interaction Comparison

ProteinTaxonomyallantoxanamide (IC50)3,4-dihydroxyphenylacetic acid (IC50)
intestinal alkaline phosphatase precursorMus musculus (house mouse)4.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Church, WH; Rappolt, G1

Other Studies

1 other study(ies) available for allantoxanamide and 3,4-dihydroxyphenylacetic acid

ArticleYear
Nigrostriatal catecholamine metabolism in guinea pigs is altered by purine enzyme inhibition.
    Experimental brain research, 1999, Volume: 127, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Allopurinol; Animals; Catecholamines; Corpus Striatum; Dopamine; Enzyme Inhibitors; Guinea Pigs; Injections; Male; Norepinephrine; Oxonic Acid; Substantia Nigra; Uric Acid

1999